Lymphoma Research Foundation: ASH 2020 - Retrospective Study Reveals Transplant Potentially Curative for Mature T-Cell Lymphoma
February 18, 2021
February 18, 2021
NEW YORK, Feb. 18 (TNSRes) -- The Lymphoma Research Foundation issued the following news:
Allogeneic hematopoietic stem cell transplant (allo-HSCT) may be a successful curative treatment for T-cell patients with poor survival and/or limited treatment options, according to a retrospective study led by LRF grantee Neha Mehta-Shah, MD of the Washington University School of Medicine in St. Louis.
As a follow-up from their 2017 study that showed 31 percent of patients remain . . .
Allogeneic hematopoietic stem cell transplant (allo-HSCT) may be a successful curative treatment for T-cell patients with poor survival and/or limited treatment options, according to a retrospective study led by LRF grantee Neha Mehta-Shah, MD of the Washington University School of Medicine in St. Louis.
As a follow-up from their 2017 study that showed 31 percent of patients remain . . .